Pfizer vaccine for kids may not be approved by FDA until November
September 29, 2021
Pfizer submitted its trial data to the FDA on Sept 28 for a COVID-19 vaccine created for kids 5 to 11, but an approval decision might not come until Thanksgiving.
Cold weather and arthritis
Dealing with seasonal affective disorder
Japan imposing new restrictions to curb the omicron variant's spread
Europe's highest ski resort opens after COVID-19 spoiled last season
How the pandemic is changing this year’s flu season
Watch as 150 baby sea turtle hatchlings make their way into the ocean
Holiday season raises concerns of a 'winter surge' as COVID cases rise in the U.S.
New Delhi to shut schools, construction sites as pollution worsens
Pandemic increased need for research on how nature boosts health
The health benefits of winter sports
This ‘tree of death’ is the most dangerous in the world
Pfizer seeks FDA booster shot approval for all adults
Transporting Martian samples to Earth causing concerns for another pandemic?
UK conditionally authorizes first pill used to treat COVID-19
FDA authorizes Pfizer’s COVID-19 vaccine for kids ages 5 to 11
Foggy day in Moscow as businesses remain closed due to COVID-19
New study reveals humans are actually made of 'stardust'
Sulfur dioxide is a hidden danger of volcanic eruptions
FDA will reportedly allow ‘mix and match’ approach for COVID booster shots
The most scenic fall hiking trails in the U.S.
Some fall favorites that will also boost your immune system
The conflicting issue of warming up your car in the winter
The dangers of shoveling snow
Pfizer seeks US COVID vaccine approval for children aged 5 to 11
Cambodian dogs learn to sniff out COVID-19 virus